Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
Residents of major cities such as Chicago or New York with high levels of air pollution have an increased risk of dry eye syndrome, U.S. researchers say. Dr. Anat Galor of the Miami Veterans Affairs Medical Center, assistant professor of ...
Tags: dry, eye, air pollution, weather condition
Can-Fite BioPharma, the parent company of OphthaliX, received a patent entitled ‘Adenosine A3 receptor agonists for the treatment of dry eye disorders including Sjogren’s syndrome’ from the European Patent Office. The ...
Tags: Can-Fite BioPharma
Provence Technologies, a service provider of specialist fine chemistry, and Neuroptis Biotech have partnered to optimize and transfer the production process for ML7, a new compound for treating dry eye syndrome. The companies have ...
Tags: ML7, dry eye syndrome, company cooperation, chemical service